ALPHA THERAPEUTIC’s FLUOSOL OXYGEN TRANSPORT FLUID APPROVED OR USE IN ANGIOPLASTY; LAUNCH WILL BE INITIATED AT CARDIOLOGIST CONFERENCE IN MARCH
Executive Summary
Alpha Therapeutic plans to launch its synthetic intravascular oxygen-carrying fluid Fluosol at the upcoming American College of Cardiology conference in New Orleans the week of March 19th.